Trial Profile
Clinical Trials Insight: 700012318
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2006
Price :
$35
*
At a glance
- Drugs MK 2295 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Merck & Co
- 20 Feb 2006 New trial record.